关于新冠肺炎疫情致外国专家和国际友人的一封信
尊敬的外国专家和朋友：
在新的一年里，新冠肺炎疫情牵动了我国乃至世界各国人民的心。我谨向您对中国疫情防控工作的关注和支持表示诚挚的感谢。
疫情发生后，中国政府第一时间建立举国体制，汇集全国资源，采取了最全面、最严格、最彻底的措施迎击疫情，其中很多措施都超出了国际卫生条例的要求和世界卫生组织的建议。国家主席习近平多次作出重要指示，主持召开会议，听取工作汇报，对疫情防控工作进行研究、部署、动员。
全国采取联防联控机制，全力收治和保障危重病人的治疗，对发现疑似病例和密切接触者就地采取必要隔离措施和医疗支持。从各方面数据监测和专家预测来看，当前疫情正在逐步得到有效控制。
中国广大科技工作者正积极投身疫情防控和医疗救治的科研攻关工作中。政府科技部门积极组织科技攻关和服务，整合生物、健康、信息等领域的力量与资源，围绕新型冠状病毒重症肺炎临床救治关键技术研究、院感综合防控技术研究、溯源与流行病学研究、致病机理研究、疫苗的开发生产、药物研发等方面，快速启动了防控新型冠状病毒感染科技攻关相关应急专项，目前在药物临床、快速试剂盒、病毒致病机理和传播途径等方面已取得了一些科研成果，为抗击疫情提供了技术支撑。例如我所在的广东省，致力于以中西医结合和国际合作研发的方式开发抗击疫情新药和老药新用，初步遴选了一些有临床效果的中药和西药；开发了15分钟快速诊断确认试剂盒，已在实验室和临床完成初步评价；开发新型隔离床和隔离诊台在本地疫情定点医院使用，有效提高院感防治水平；疫苗研发有望在近期取得阶段性进展，流行病溯源研究取得进展。广东省实验动物监测所已成功合成新型冠状病毒N蛋白表达菌株，率先免费开放共享，缩短全国科研人员的研发时间，节约研发经费，引导树立正确科研价值导向，到目前，已向中国及国际上的科研机构、团队提供1090份。机器人、AI、大数据、无人机等技术也在疫情防控工作中被广泛应用，充分利用科技抗击疫情。全省防控疫情依法科学有力有效，社会稳定，各类生活必需品市场供应充足，公共交通正常运转，医疗物资、生活物资、防疫工作运输畅通，正积极迎接返粤复工人流，扶持企业分类有序复工复产。同时，关于广东我想告诉您的是，自2003年成功抗击非典疫情之后，广东大力加强传染病防控科研能力建设，防控机制不断完善，近年成功识别和阻断H1N1、MERS等爆发在其他国家的流行病输入和传播，至今再未发生大规模传染病。
中国人民和政府对世界上其他国家爆发的疫病感同身受，积极提供人道主义援助，帮助疫病国家地区开发疫苗和诊断治疗方法。比如成功研制出甲型H1N1流感疫苗,与其他国家合作共同成功开发了目前针对MERS病毒最好的治疗药物之一的全人源单克隆抗体(m336)，开展资助包括科摩罗、巴布亚新几内亚等疟疾流行国家全民服药援助计划，取得卓然成效，也积累了防控疫情的丰富技术经验。
这次疫情发生以来，中国政府本着高度负责的态度，积极主动开展国际合作，第一时间向世界卫生组织通报疫情以及分享有关技术信息，如毒株的全基因组序列等。在中国国家卫生健康委员会官方网站上，每日更新汇总全国疫情变化数据，实时向全世界发布。在应对疫情的科技攻关中，我们积极拓展与国际组织和相关国家的科技合作。例如广东省已与美国、加拿大、德国、以色列等国家的科学家开展了疫情相关联合研究，同时欢迎更多外国专家来粤合作，并提供专门防疫住宿保障。广东抗击疫情的领军专家钟南山院士和我本人于1月30日在广州分别会见了世界著名“病毒猎手”美国哥伦比亚大学感染与免疫研究中心的利普金教授，就广东疫情应对情况与其进行了交流，支持其与本地机构开展在流行病防控领域的科研合作。
病毒没有国界，疫情是全人类共同面对的挑战。中国发生疫情以来，多个国家对中国进行了医疗物资援助，开展抗疫科研合作。对于这些善意，我们深表感谢。我还关注到，欧盟、相关国际组织及有关国家就新型冠状病毒已发布开展国际联合研究的项目招标。我们相信，通过国际社会的共同努力，我们一定能在不久的将来打赢这场疫情防控阻击战。“患难见真情”，经历风雨，我们的友谊必将历久弥坚，我们的合作将更加牢固。
诚恳希望您继续关注和支持我们。疫情过后，中国将依然是那个充满活力的安全国度，欢迎您来参加国际会议、工作、生活、交流，我们期盼着与您重逢在春暖花开之时。
祝您在新的一年里幸福安康！
联合国科技促进发展委员会（UNCSTD）第22届副主席/广东省科学技术厅厅长 王瑞军博士
2020年2月19日
A Letter to Foreign Experts and Friends
Dear Foreign Experts, Friends,
In this new year, the whole nation of China and the world are concerned with the outbreak of the novel coronavirus epidemic. I would like to extend my heartfelt gratitude for your concern and support for this epidemic control and prevention in China.
After the outbreak, the Chinese government immediately set up a nationwide mechanism to mobilize resources from across the country. We have taken the most comprehensive, stringent and thorough prevention and control measures, many of which are well beyond what is required by the International Health Regulations and the recommendations of World Health Organization (WHO). President Xi Jinping has made important instructions several times on the epidemic control and prevention. He has chaired central government meetings and listened to work reports to study the situation, to deploy solutions and to mobilize the state for this work of top priority. The whole country adopts a joint prevention and control mechanism headed by the state council. Under this mechanism, All possible measures are taken to fully receive and guarantee the medical treatment of critical patients infected with COVID-19 in hospitals. Every effort is made to take necessary quarantine measures and provide medical support for all suspected cases and close contacts. Based on the real time monitoring of case data and experts’ predication, the epidemic tends to be effectively under control. For example, outside Hubei province, the daily adding number of confirmed cases has been declining for 15 consecutive days across China with a cumulative drop of over 70%; there is a rapid increase in the cure rate and over 10,000 people have recovered and been discharged from hospital.
Vast group of scientific and technological practitioners in China are intensively engaged in research to tackle the problems in epidemic curb and medical treatment. The governmental scientific and technological organs have launched several emergency-tackling research programs on the novel coronavirus disease prevention and control in related areas including key technologies for clinical treatment of severe pneumonia case of COVID-19, comprehensive research on hospital infection prevention and control, traceability and epidemiological studies, pathogenesis research, development and production of vaccine, and drug research and development, etc. At present, some research achievements have been made in clinical drug, rapid-test kits, virus pathogenesis and transmission channels, which provide technical support for fight against the epidemic. For example, in Guangdong province where I live and work, we are committed to the development of new anti-epidemic drugs and new use of old drugs in the way of integration of traditional Chinese and Western medicine and international cooperative research. We have successfully selected some Chinese and Western medicines with clinical effect. A local research team has developed a 15-minute rapid diagnostic kit, which has finished the preliminarily evaluation in laboratory and in clinical use. New type of isolation bed and isolation diagnosis platform have been developed and used in local designated hospitals to improve the level of nosocomial infection prevention and control. Vaccine research and development is expected to make stage progress in the near future, and research on epidemic traceability is making progress. The Recombinant SARS-CoV-2 virus N protein has been successfully synthesized inGuangdong Laboratory Animal Monitoring Institute, and is shared for free with the whole world to shorten the related research with less R&D expenditure, and to guide the establishment of correct scientific research value orientation. So far, more than 1090 strain samples have been given out to domestic and international research teams. Moreover, robot, AI, big data, UAV and other technologies are widely used to support epidemic prevention and control. Guangdong has taken law-based, scientific, robust and effective measures in curbing the epidemic. As such, the society is stable with sufficient supply of daily necessities, functional public transportation, and smooth transportation for medical, essential and epidemic control related supplies. The province is welcoming the flow of migrant workers to return to work and is supporting enterprises to resume production in a classified and orderly manner. I would also like to share the following facts of Guangdong with you. Since the victory of our battle against SARS in 2003, Guangdong has been focusing on its capacity building in R&D of epidemic management. The prevention and control mechanism being constantly improving. In recent years, it has successfully identified and blocked local spread of H1N1, MERS and other viruses that became epidemic in other countries. So far, no more scale epidemics happen in the province again.
The Chinese government and people have always showed empathy for the epidemic outbreaks in other countries and regions by providing humanitarian assistance as well as helping to develop vaccines, clinical diagnosis and drugs. For example, we have successfully developed influenza A (H1N1) vaccine. In cooperation with other countries, we have accomplished the development of fully humanized monoclonal antibody (m336), which becomes one of the best therapeutic drugs for MERS. We have also developed anti-malaria drugs and funded the mass drug administration programs in countries such as Comoros and Papua New Guinea where people suffered from malaria. Remarkable results have been achieved and related experiences have been accumulated.
As a responsible country, the Chinese government has from the start acted in an open and transparent manner in releasing relevant information and seeking international cooperation to prevent the spread of the epidemic worldwide. We have shared with WHO relevant technical information such as the whole genome sequence of the virus strain at a very early time. On the official website of the National Health Commission of China, real time data of national epidemic changes are updated daily to the whole world. At the same time, we actively expand scientific and technological cooperation with international organizations and other countries in response to the epidemic.For example, joint research with scientists from the United States, Canada, Germany, Israel and other countries in epidemic related research are progressing in Guangdong. More foreign experts are welcome to the province for joint research and special accommodation for epidemic prevention will be provided. On January 30th in Guangzhou,renowned Chinese respiratory expert Nanshan Zhong and I met with the world-famous Virus Hunter, Professor Walter Ian Lipkin from the Center for Infection and Immunity at Columbia’s Mailman School of Public Health respectively. We exchanged with him the response to the epidemic in Guangdong and I supported him to carry out scientific research cooperation with local institutions in the field of epidemic prevention and control.
Virus respects no borders. Epidemic caused by viral infectious disease represents a challenge for all mankind. Since the outbreak of this epidemic in China, many countries have provided medical material assistance to us and developed international joint research projects for epidemic containing. We are truly grateful for these acts of kindness. I also notice that calls for international joint research projects on related studies of novel coronavirus epidemic have been issued by the European Union, some international organizations and other countries. We believe that, with the joint efforts of international community, we will surely win this battle against the epidemic in the near future. Adversity reveals true friendship. Emerging from this test, our friendship will be strengthened and our cooperation will become even firmer.
Your sustaining concern and support will be much appreciated. After the epidemic , that dynamic and secure country will come back again. Welcome you to return for international meetings, for work, for stay and for further exchanges. We are looking forward to meeting you again in the spring blossoms.
I wish you happiness and health in the New Year!
Dr. Ruijun Wang
Director General of Department of Science and Technology of Guangdong Province, P.R.C
Vice-Chairman of the 22nd Session, UNCSTD
19th February, 2020
来源：省科技厅网站